TESARO Inc (TSRO) Price Target Cut to $164.00 by Analysts at Wedbush

TESARO Inc (NDAQ:TSRO) had its price objective decreased by Wedbush from $200.00 to $164.00 in a research note issued to investors on Wednesday. Wedbush currently has an outperform rating on the stock.

Several other research analysts have also recently weighed in on the stock. FBR & Co cut shares of TESARO from an outperform rating to a market perform rating and upped their price target for the company from $151.00 to $202.00 in a report on Thursday, February 16th. Royal Bank of Canada upped their price target on shares of TESARO from $142.00 to $202.00 and gave the company an outperform rating in a report on Friday, February 17th. Leerink Swann cut shares of TESARO from an outperform rating to a mkt perform rating in a report on Friday, February 10th. Finally, Robert W. Baird cut shares of TESARO from an outperform rating to a neutral rating and upped their price target for the company from $127.00 to $182.00 in a report on Monday, February 27th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. TESARO has a consensus rating of Buy and a consensus target price of $187.50.

TESARO (NDAQ:TSRO) opened at 152.05 on Wednesday. The firm’s market capitalization is $8.15 billion. TESARO has a 1-year low of $36.68 and a 1-year high of $192.94. The company has a 50-day moving average of $173.60 and a 200-day moving average of $135.82.

Your IP Address:

About TESARO

TESARO, Inc is an oncology-focused biopharmaceutical company. The Company acquires, in-licenses and develops oncology product candidates. It operates in business of developing and commercializing oncology-focused therapeutics segment. It has in-licensed and are developing oncology-related product candidates, including intravenous (IV) rolapitant and niraparib, as well as product candidates under its immuno-oncology platform.

Receive News & Ratings for TESARO Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TESARO Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.